Khalima Bolden, Ph.D.

Khalima Alicia Bolden, Ph.D.

Specialties

Clinical Psychology

Developmental Neuropsychology

Psychosis

Trauma Focused Cognitive Behavioral Therapy

Title

  • Assistant Health Sciences Clinical Professor
  • Assistant Director of Clinical Training at the UC Davis Early Psychosis Programs

Reviews

Psychiatry and Behavioral Sciences

2230 Stockton Blvd.
Sacramento, CA 95817
Driving Directions

Primary Phone:
916-734-3574

Additional Phone Numbers

Clinic Phone: 916-734-3350
Clinic Fax: 916-734-7539
Clinic Referral Phone: 916-734-2571
Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Emails

Center/Program:
kbolden@ucdavis.edu

Clinical Interests

Dr. Khalima A. Bolden is a licensed clinical psychologist and the Assistant Director of Clinical Training at the UC Davis Early Psychosis Program. Dr. Bolden received her Ph.D. in Clinical Psychology from the San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology after completing her internship at UCLA in the Adolescent Serious Mental Illness track. She went on to complete a postdoctoral fellowship in Clinical Psychology at Vanderbilt University Medical Center in the Psychosis track. During her internship she was trained in the administration and interpretation of gold standard psychodiagnostic assessments and trained in the administration of Family Focused Therapy (FFT) and was supervised by the founder of the practice, Dr. David Miklowitz. During her postdoctoral fellowship she focused on clinical and neuropsychological assessment and intervention of individuals with suspected psychosis spectrum disorders. Dr. Bolden has extensive training in Cognitive Behavior Therapy for Psychosis, Family Focused Therapy, Trauma-Focused CBT, and the use of Cognitive Remediation training in psychiatric populations. In her role at the UC Davis Early Psychosis Program, Dr. Bolden provides service and supervision of evidence-based treatment and assessment approaches for early psychosis youth, with an emphasis on Family Focused Therapy and Cognitive Remediation. Since arriving at UC Davis, Dr. Bolden has actively served on the Department of Psychiatry's Diversity Advisory Committee, and is involved in recruitment activities focused on increasing diversity and inclusion in both the department and in the health system. Dr. Bolden has also demonstrated her commitment to excellence in teaching and education and has lectured courses on social determinants of health in both the medical and nursing schools. 

Research/Academic Interests

Dr. Bolden also has an active and rich research which focuses on examining sociocultural factors associated with risk for psychosis and access to care. Dr. Bolden has specific expertise in the impact of systemic marginalization of African Americans both in society and in the healthcare system on the mischaracterization of psychosis symptoms in this population as well as the role of intergenerational and contemporary trauma on this population as a key stressor contributing to psychosis symptoms in this group.

Division

General Psychiatry

Education

M.A., Psychology, Boston University, Boston MA 2010

Ph.D., Clinical Psychology, San Diego State University/UC San Diego, La Jolla CA 2016

B.S., Tufts University, Medford MA 2005

Internship: Adolescent Serious Mental Illness track, UCLA (Center for the Assessment and Prevention of Prodromal States), Los Angeles CA 2015-2016

Fellowships

Early Psychosis Track, Vanderbilt University Medical Center, Nashville TN 2016-2017

Board Certifications

California Board of Psychology,

Select Recent Publications

Linton SR, Popa AM, Luck SJ, Bolden KA, Carter CS, Niendam TA, Simon TJ. Atypical attentional filtering of goal-directed visual information and the impact of emotional salience in youth with chromosome 22q11.2 indexed by event-related potentials (ERPs). Submitted to J Abnormal Psychiatry. 2020.

Anglina DM, Ereshefsky SH, Klaunigd MJ, Bridgwaterd MA, Niendamc TA, Ellman LM, DeVylder J, Thayer G, Bolden KA, Musket CW, Grattan RE, Lincoln SH, Schiffmand J, Lipner E, Bachman P, Corcoran CM, Mota NB, van der Ven E. From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the U.S. Submitted to Schizophrenia Bulletin. 2020.

Linton S, Popa A, Luke S, Bolden KA, Carter C, Niendam T, Simon T. Neural and Behavioral Measures Suggest That Cognitive & Affective Functioning Interactions Mediate Risk for Psychosis-Proneness Symptoms in Youth with Chromosome 22q11.2 Deletion Syndrome. Am J Med Genetics. 2019;182(7):1615-1630. doi:10.1002/ajmg.a.61596.

Folk JB, Tully LM, Blacker DM, Liles BD, Bolden KA, Tryon V, Botello R, Niendam TA. Uncharted waters: Treating trauma symptoms in the context of early psychosis. J Clin Med. 2019;8(9):1456. Published online 2019 Sep 12. doi:10.3390/jcm8091456. PMID:31547447.

Mayo D, Bolden KA, Simon TJ, Niendam TA. Bullying and psychosis: The impact of chronic stress on psychosis risk in 22q, a uniquely vulnerable population. J Psychiatr Res. 2019 Jul;114:99-104. doi:10.1016/j.jpsychires.2019.04.011. Epub 2019 Apr 15. PMID:31054456.

Meyer M, Rosenthal A, Bolden KA, Shim R, Rodriguez J, Pavao E, Niendam TA. Does early psychosis screening belong in schools? Early Intervention in Psychiatry. 2019. Epub ahead of print.

Cattie JE, Marquine MJ, Bolden KA, Obermeit LC, Morgan EE, Franklin DR, Umlauf A, Beck JM, Atkinson JH, Grant I, Woods SP, The TMARC Group. Predictors of Attrition in a Cohort Study of HIV Infection and Methamphetamine Dependence. J Subst Use. 2015;20(6):407-416. Published online 2015 Feb 3. doi:10.3109/14659891.2014.942397.

Kamat R, Brown GG, Bolden KA, Marcotte TD, Letendre SL, Ellis RJ, Woods SP, Heaton RK, Grant I, the TMARC Group. Apathy is associated with white matter abnormalities in anterior, medial regions in persons with HIV. J Clin Exp Neuropsychol. 2014;36(8):854-66. doi:10.1080/13803395.2014.950636. Epub 2014 Oct 2.

Mano QR, Brown GG, Mirzakhanian H, Bolden KA, Cadenhead KS, Light G. Not all distraction is bad: Working memory vulnerability to implicit emotional distraction correlates with negative symptoms and functional impairment in psychosis. Schizophr Res Treat. 2014;2014:320948. doi:10.1155/2014/320948. Epub 2014 Feb.

Obermeit LC, Cattie JE, Bolden KA, Marquine M, Morgan EE, Franklin DR, Atkinson JH, Grant I, Woods SP, the TMARC Group. Attention-Deficit/Hyperactivity Disorder among chronic methamphetamine users: Frequency, persistence, and adverse effects on everyday functioning. Addict Behav. 2013 Dec;38(12):2874-8.  doi:10.1016/j.addbeh.2013.08.010. Epub 2013 Aug 19.